Sinopharm Group Co Ltd operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sinopharm Group Co Ltd with three other
drug stores in Asia:
Suzuken Co., Ltd.
sales of 2.23 trillion Japanese Yen [US$19.94 billion]
of which 93%
was Pharmaceutical Wholesale Business),
Alfresa Holdings Corporation
(2.58 trillion Japanese Yen [US$23.06 billion]
of which 88%
was Wholesale Business of Pharmaceuticals fo), and
Medipal Holdings Corporation
based in Japan
(3.03 trillion Japanese Yen [US$27.10 billion]
of which 70%
was Pharmaceuticals And Food Precessing Whol).
During the year ended December of 2016, sales at
Sinopharm Group Co Ltd were 228.67 billion Chinese Renmimbi (US$33.19 billion).
a very small
increase of 0.7%
versus 2015, when the company's sales were 227.07 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Sinopharm Group Co Ltd
(and since 2011, sales have increased a total of 124%).
Sales of Retail Pharmacy Operations saw an increase
that was more than double the company's growth rate: sales were up
17.1% in 2016, from
8.71 billion Chinese Renmimbi to 10.20 billion Chinese Renmimbi.
Sinopharm Group Co Ltd also saw significant increases in sales in
Pharmaceutical Distribution (up 14.0% to 243.88 billion Chinese Renmimbi)
Not all segments of Sinopharm Group Co Ltd experienced an increase in sales in 2016:
sales of Other Business Operations fell 1.3% to 4.30 billion Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).